Home » Marijuana & CBD » Page 3

Marijuana & CBD

Featured posts

Breaking News: DOT issues update to Oral Fluid Final Rule, allowing collector training to begin December 5, 2024

NDASA is pleased to announce both the most recent DOT final rule addressing oral fluid collections and the beginning of oral fluid collector training - effective December 5, 2024! In today's Federal Register, the U.S. Department of Transportation's (DOT) Office...
Read More

What does marijuana legalization mean for employee retention?

Jonathan Baktari, MD, CEO, US Drug Test Centers Research tells us that approximately 3.8% of the world’s population (or 158.8 million people) uses marijuana. In 2023, about 17% of Americans reported smoking marijuana, which was higher than in previous years. And —...
Read More

DOT Electronic CCF Notice of Proposed Rulemaking

NDASA is pleased to announce a long-awaited and very welcomed Notice of Proposed Rulemaking In the NPRM, published on Tuesday, October 15, the U.S. Department of Transportation's (DOT) Office of Drug and Alcohol Policy and Compliance (ODAPC) and the Pipeline and...
Read More

Podcast: Member's Memo

Updates on relevant industry news, compliance issues, regulatory changes and upcoming events.
Listen now

All posts

Buyer beware: CBD, THC and drug testing

Buyer beware: CBD, THC and drug testing

by | Jul 3, 2020 | ,

Is CBD medicine or isn’t it? Is it safe? Can it impact a drug test result? Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation. There is a great deal of uncertainty about cannabis and cannabinoid...